Drugs for asthma

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

adrenoceptor agonist; Asthma; Bronchodilator; Corticosteroids; Cromoglycate; Muscarinic antagonist; Theophylline

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; ATROPINE; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BUDESONIDE; CHROMONE DERIVATIVE; CICLESONIDE; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; EPHEDRINE; FLUTICASONE; FORMOTEROL; GLYCOPYRRONIUM BROMIDE; HYDROCORTISONE; IPRATROPIUM BROMIDE; ISOETARINE; ISOPRENALINE; KHELLIN; MUSCARINIC RECEPTOR BLOCKING AGENT; QUATERNARY AMMONIUM DERIVATIVE; SALBUTAMOL; SALMETEROL; SCOPOLAMINE; TIOTROPIUM BROMIDE; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BLOOD BRAIN BARRIER; BRONCHODILATATION; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DATURA; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; ECZEMA; GROWTH DISORDER; HALLUCINATION; HUMAN; HYOSCYAMUS; LOW DRUG DOSE; METABOLIC DISORDER; NAUSEA; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHROMONES; DRUG THERAPY, COMBINATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFLAMMATION MEDIATORS; PORTRAITS; THEOPHYLLINE;

EID: 30444457031     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706437     Document Type: Review

References (40)

1. AHLQUIST, R.P. (1948). A study of adrenotropic receptors. Am. J. Physiol., 153, 586.
2. ASH, A.S.P. & SCHILD, H.O. (1966). Receptors mediating some actions of histamine. Br. J. Pharmac. Chemother., 27, 427-439.
3. BALL, D.I., BRITTAIN, R.T., COLEMAN, R.A., DENVER, L.H., JACK, D., JOHNSON, M., LUNTS, L.H., NIALS, A.T., SHELDRICK, K.E. & SKIDMORE, I.F. (1991). Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665-671.
4. BARGER, G. & DALE, H.H. (1910). Chemical structure and sympathomimetic action of amines. J. Physiol., 41, 19-59.
5. BARNES, P.J. (2002). Scientific rationale for combination inhalers with a long-acting β2-agonists and corticosteroids. Eur. Respir. J., 19, 182-191.
6. BARNES, P.J. (2003). Theophylline: new perspectives on an old drug. Am. J. Respir. Crit. Care Med., 167, 813-818.
7. BARNES, P.J. (2004). New drugs for asthma. Nat. Rev. Drug Discov., 3, 831-844.
8. BARNES, P.J. & ADCOCK, I.M. (2003). How do corticosteroids work in asthma? Ann Intern. Med., 139, 359-370.
9. BARNES, P.J., CHUNG, K.F. & PAGE, C.P. (1998). Inflammatory mediators of asthma: an update. Pharmacol. Rev., 50, 515-596.
10. BEEH, K.M., SCHELFOUT, V., GRONKE, F., KANNIESS, F., CAMERON, R. & VAN AS, A. (2005). QAB149: the first once-daily β2-agonist with 24-h bronchodilation. Proc. Amer. Thorac. Soc., 2, A356.
11. BOARDLEY, J.E., CAREY, R.A. & HARVEY, A.M. (1949). Preliminary observations on the effect of adrenocorticotropic hormone in allergic diseases. Bull. Johns. Hopkins. Hosp., 85, 396-410.
12. BREWIS, R.A.L. (1990). Classical Papers in Asthma. London: Science Press.
13. BRITTAIN, R.T., FARMER, J.B., JACK, D., MARTIN, L.E. & SIMPSON, W.T. (1968). Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature, 219, 862-863.
14. BROCKLEHURST, W.E. (1960). The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J. Physiol., 151, 416-435.
15. BROWN, H.M., STOREY, G. & GEORGE, W.H. ( 1972). Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. BMJ, 1, 585-590.
16. COLLIER, J.G. & DORNHORST, A.C. (1969). Evidence for two different types of beta-receptors in man. Nature, 223, 1283-1284.
17. COX, J.S.G. (1967). Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature, 216, 1328-1329.
18. CULLUM, V.A., FARMER, J.B., JACK, D. & LEVY, G.P. (1969). Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br. J. Pharmacol., 35, 141-151.
19. CURRY, J.J. (1946). The action of histamine on the repiratory tract in normal and asthmatic subjects. J. Clin. Invest., 25, 785-791.
20. DALE, H.H. & LAIDLAW, P.P. (1910). The physiological action of β-iminazoly-ethylamine. J. Physiol., 41, 318-341.
21. FELDBERG, W. & KELLAWAY, C.H. (1938). Liberation of histamine and formation of lysocithin-like substances by cobra venom. J. Physiol., 94, 187-226.
22. FRYER, A.D. & MACLAGAN, J. (1984). Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br. J. Pharmacol., 83, 973-978.
23. HANSEL, T.T. & BARNES, P.J. (2002). Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today, 38, 585-600.
24. HERMANN, G.R., AYNESWORTH, M.B. & MARTIN, J. (1937). Succesful treatment of persistent extreme dyspnea 'Status asthmaticus' - use of theophylline ethylene diamine. J. Lab. Clin. Med., 23, 135-148.
25. HIRSCH, S. (1922). Klinischer und experimenteller Beitrag zur krampfloseneden Wirkung der Purin Derivativ. Klin. Wochenschr., 1, 615-618.
26. HOWELL, J.B. & ALTOUNYAN, R.E. (1967). A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet, 2, 539-542.
27. ITO, K., LIM, S., CARAMORI, G., COSIO, B., CHUNG, K.F., ADCOCK, I.M. & BARNES, P.J. (2002). A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. U.S.A., 99, 8921-8926.
28. KARLSSON, I.A. & PERSSON, C.G. (1981). Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline. Br. J. Pharmacol., 74, 73-79.
29. LANDS, A.M., ARNOLD, A., MCAULIFF, J.P., LUDUENA, F.P. & BROWN JR, T.G. (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature, 214, 597-598.
30. MACHT, D. & TING, G.C. (1921). A study of antispasmodic drugs on the bronchus. J. Pharmacol. Exp. Ther., 18, 373-398.
31. MCKENZIE, A.W. & STOUGHTON, R.B. (1962). Method for comparing percutaneous absorption of steroids. Arch. Dermatol., 86, 608-610.
32. MEDICAL RESEARCH COUNCIL. (1956). Controlled trial of effects of cortisone acetate in status asthmaticus; report to the Medical Research Council by the subcommittee on clinical trials in asthma. Lancet, 271, 803-806.
33. MINETTE, P.A. & BARNES, P.J. (1988). Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea-pig airways. J. Appl. Physiol., 64, 2532-2537.
34. MITENKO, P.A. & OGILVIE, R.I. (1973). Rational intravenous doses of theophylline. New Engl. J. Med., 289, 600-603.
35. MURPHY, R.C., HAMMARSTROM, S. & SAMUELSSON, B. (1979). Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. U.S.A., 76, 4275-4279.
36. NORRIS, A.A. & ALTON, E.W. (1996). Chloride transport and the action of sodium cromoglycate and nedocromil sodium in asthma. Clin. Exp. Allergy, 26, 250-253.
37. PIPER, P.J. & SAMHOUN, M.N. (1982). Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro. Br. J. Pharmacol., 77, 267-275.
38. SCHILD, H.O., HAWKINS, D.F., MONGAR, J.L. & HERXHEIMER, H. (1951). Reaction of isolated human and asthmatic lung and bronchial tissue to a specifci antigen. Histamine release and muscular contraction. Lancet, 2, 376-382.
39. SOLIS-COHEN, S. (1900). The use of adrenal substances in the treatment of asthma. JAMA, 34, 1164-1169.
40. ULLMAN, A. & SVEDMYR, N. (1988). Salmeterol, a new long acting inhaled β2-adrenoceptor agonist: comparison with salbuterol in adult asthmatic patients. Thorax, 43, 674-678.